#uk-life-sciences

[ follow ]
#pharmaceutical-investment #pharmaceutical-industry #nhs-drug-pricing #us-trade-policy #clinical-trials
UK politics
fromwww.theguardian.com
7 months ago

Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he's menacing Britain | Polly Toynbee

US tariff threats and pricing demands are pushing UK pharmaceutical investment away, undermining British life sciences and straining NHS drug-price negotiations.
#pharmaceutical-investment
more#pharmaceutical-investment
UK politics
fromwww.theguardian.com
7 months ago

US drugmaker Merck scraps 1bn London research centre and cuts 125 science jobs

Merck has scrapped a 1bn London research centre, will discontinue UK discovery research and lay off about 125 scientists while relocating research operations elsewhere.
Canada news
fromwww.theguardian.com
10 months ago

If AstraZeneca goes to the US it will be a major blow for London and Labour

Pascal Soriot is considering moving AstraZeneca's corporate base to the US, impacting the company's UK presence and raising concerns in the scientific community.
[ Load more ]